This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Phosphoinositide 3-kinase 3D structures
From Proteopedia
(Difference between revisions)
| (One intermediate revision not shown.) | |||
| Line 23: | Line 23: | ||
**[[3mtt]], [[3o5z]] – hPI3KI p85β <br /> | **[[3mtt]], [[3o5z]] – hPI3KI p85β <br /> | ||
**[[2kt1]] - hPI3KI p85β SH3 domain<br /> | **[[2kt1]] - hPI3KI p85β SH3 domain<br /> | ||
| - | **[[3l4q]] – | + | **[[6ox7]], [[6u28]] – hPI3KI p85β + influenza NS1 protein <br /> |
| + | **[[3l4q]] – bPI3KI p85β + influenza NS1 protein <br /> | ||
*'''Class II''' | *'''Class II''' | ||
| Line 46: | Line 47: | ||
**[[3hiz]], [[4jps]] - hTI-PI3K p110α (mutant) + p85α <br /> | **[[3hiz]], [[4jps]] - hTI-PI3K p110α (mutant) + p85α <br /> | ||
**[[2rd0]], [[4l1b]], [[6nct]] - hTI-PI3K p110α + p85α<br /> | **[[2rd0]], [[4l1b]], [[6nct]] - hTI-PI3K p110α + p85α<br /> | ||
| + | **[[7myn]] - hTI-PI3K p110α + p85α – Cryo EM<br /> | ||
**[[5sxk]], [[5sx8]], [[5sx9]], [[5sxa]], [[5sxb]], [[5sxc]], [[5sxd]], [[5sxe]], [[5sxf]], [[5sxi]], [[5sxj]], [[5sw8]], [[5swg]], [[5swo]], [[5swp]], [[5swr]], [[5swt]], [[5dxh]], [[5xgj]], [[5xgi]]], [[5xgh]] - hTI-PI3K p110α + p85α + inhibitor<br /> | **[[5sxk]], [[5sx8]], [[5sx9]], [[5sxa]], [[5sxb]], [[5sxc]], [[5sxd]], [[5sxe]], [[5sxf]], [[5sxi]], [[5sxj]], [[5sw8]], [[5swg]], [[5swo]], [[5swp]], [[5swr]], [[5swt]], [[5dxh]], [[5xgj]], [[5xgi]]], [[5xgh]] - hTI-PI3K p110α + p85α + inhibitor<br /> | ||
**[[5ul1]], [[5ukj]], [[5itd]], [[5fi4]], [[4zop]] - hTI-PI3K p110α (mutant) + p85α + inhibitor<br /> | **[[5ul1]], [[5ukj]], [[5itd]], [[5fi4]], [[4zop]] - hTI-PI3K p110α (mutant) + p85α + inhibitor<br /> | ||
**[[5uk8]] - hTI-PI3K p110α (mutant) + p85α (mutant) + inhibitor<br /> | **[[5uk8]] - hTI-PI3K p110α (mutant) + p85α (mutant) + inhibitor<br /> | ||
| + | **[[7myo]] - hTI-PI3K p110α + p85α + inhibitor – Cryo EM<br /> | ||
**[[4ovu]] - hTI-PI3K p110α + p85α SH2 domain<br /> | **[[4ovu]] - hTI-PI3K p110α + p85α SH2 domain<br /> | ||
**[[4ovv]] - hTI-PI3K p110α + p85α SH2 domain + phosphatidylinositol-4,5-bisphosphate <br /> | **[[4ovv]] - hTI-PI3K p110α + p85α SH2 domain + phosphatidylinositol-4,5-bisphosphate <br /> | ||
| Line 57: | Line 60: | ||
*Type I PI3K p110α | *Type I PI3K p110α | ||
| - | **[[4tuu]], [[4tv3]] - hTI-PI3K p110α<br /> | + | **[[4tuu]], [[4tv3]], [[8bfu]] - hTI-PI3K p110α catalytic subunit 105-1048<br /> |
| - | **[[2enq]] - hTI-PI3K p110α C2 domain<br /> | + | **[[7pg5]] - hTI-PI3K p110α catalytic subunit (mutant) + regulatory subunit 307-593<br /> |
| - | **[[3zim]], [[4a55]], [[4oys]], [[4ph4]], [[4uwf]], [[4uwg]], [[4uwh]], [[4uwk]], [[4uwl]], [[5ubr]], [[5dxt]], [[4ykn]], [[6pys]], [[6oac]], [[6gvi]], [[6gvh]], [[6gvg]], [[6gvf]] - hTI-PI3K p110α + inhibitor<br /> | + | **[[7pg6]], [[7tz7]], [[8sbc]] - hTI-PI3K p110α catalytic subunit (mutant) + regulatory subunit 1-293 inhibitor<br /> |
| + | **[[2enq]] - hTI-PI3K p110α C2 domain 331-481<br /> | ||
| + | **[[6vo7]] - hTI-PI3K p110α RBD 157-300<br /> | ||
| + | **[[3zim]], [[4a55]], [[4oys]], [[4ph4]], [[4uwf]], [[4uwg]], [[4uwh]], [[4uwk]], [[4uwl]], [[5ubr]], [[5dxt]], [[4ykn]], [[6pys]], [[6oac]], [[6gvi]], [[6gvh]], [[6gvg]], [[6gvf]], [[7k6m]], [[7k6n]], [[7k6o]], [[7k71]], [[7mlk]], [[7r9v]], [[7r9y]], [[8exo]], [[8exu]], [[8exv]], [[8sbj]] - hTI-PI3K p110α catalytic subunit + inhibitor<br /> | ||
| + | **[[8ow2]] - hTI-PI3K p110α catalytic subunit + activator <br /> | ||
| + | **[[8exl]] - hTI-PI3K p110α catalytic subunit + drug <br /> | ||
| + | **[[8gua]], [[[8gub]], [[8gud]] - hTI-PI3K p110α catalytic subunit (mutant) + drug – Cryo EM<br /> | ||
| + | **[[8dcp]], [[8dcx]], [[8dd4]], [[8dd8]] - hTI-PI3K p110α catalytic subunit + regulatory subunit 3-724 + nanobody – Cryo EM<br /> | ||
| + | **[[7cio]] - hTI-PI3K p110α C2 domain + CTLA-4<br /> | ||
| + | **[[7bi4]] - mTI-PI3K p110α C2 domain (mutant)<br /> | ||
| + | **[[7bi9]], [[7z74]], [[7z75]], [[8a9i]] - mTI-PI3K p110α C2 domain + inhibitor<br /> | ||
| + | **[[7bi6]] - mTI-PI3K p110α C2 domain + ATP<br /> | ||
*Type I PI3K p110β | *Type I PI3K p110β | ||
| Line 72: | Line 86: | ||
**[[3l08]] – hTI-PI3K p110γ + GSK2126458 <br /> | **[[3l08]] – hTI-PI3K p110γ + GSK2126458 <br /> | ||
**[[3ibe]]– hTI-PI3K p110γ + pyrazolopyrimidine <br /> | **[[3ibe]]– hTI-PI3K p110γ + pyrazolopyrimidine <br /> | ||
| - | **[[3ene]], [[2v4l]], [[2a4z]], [[2a5u]], [[1e7u]], [[1e7v]], [[1e8w]], [[1e8y]], [[1e8z]], [[1e90]], [[1e8x]], [[3tls]], [[3apc]], [[3apd]], [[3apf]], [[3s2a]], [[3r7q]], [[3r7r]], [[3p2b]], [[3mjw]], [[3nzs]], [[3nzu]], [[3qaq]], [[3qar]], [[3zvv]], [[3zw3]], [[3sd5]], [[3t8m]], [[3tl5]], [[4anu]], [[4anv]], [[4anw]], [[4anx]], [[4aof]], [[4dk5]], [[4f1s]], [[4fa6]], [[4fad]], [[4fhj]], [[4fhk]], [[4fjy]], [[4fjz]], [[4flh]], [[4ful]], [[4g11]], [[4gb9]], [[4hle]], [[4hvb]], [[4j6i]], [[4ps3]], [[4ps7]], [[4ps8]], [[4urk]], [[4wwn]], [[4wwo]], [[4wwp]], [[5t23]], [[5kae]], [[5jhb]], [[5jha]], [[5g55]], [[5g2n]], [[5eds]], [[4xz4]], [[4xx5]], [[6gq7]], [[6fh5]], [[6t3b]], [[6t3c]], [[6xrl]], [[6xrm]] – hTI-PI3K p110γ + inhibitor <br /> | + | **[[3ene]], [[2v4l]], [[2a4z]], [[2a5u]], [[1e7u]], [[1e7v]], [[1e8w]], [[1e8y]], [[1e8z]], [[1e90]], [[1e8x]], [[3tls]], [[3apc]], [[3apd]], [[3apf]], [[3s2a]], [[3r7q]], [[3r7r]], [[3p2b]], [[3mjw]], [[3nzs]], [[3nzu]], [[3qaq]], [[3qar]], [[3zvv]], [[3zw3]], [[3sd5]], [[3t8m]], [[3tl5]], [[4anu]], [[4anv]], [[4anw]], [[4anx]], [[4aof]], [[4dk5]], [[4f1s]], [[4fa6]], [[4fad]], [[4fhj]], [[4fhk]], [[4fjy]], [[4fjz]], [[4flh]], [[4ful]], [[4g11]], [[4gb9]], [[4hle]], [[4hvb]], [[4j6i]], [[4ps3]], [[4ps7]], [[4ps8]], [[4urk]], [[4wwn]], [[4wwo]], [[4wwp]], [[5t23]], [[5kae]], [[5jhb]], [[5jha]], [[5g55]], [[5g2n]], [[5eds]], [[4xz4]], [[4xx5]], [[6gq7]], [[6fh5]], [[6q6y]], [[6q73]], [[6q74]], [[6t3b]], [[6t3c]], [[6xrl]], [[6xrm]], [[6xrn]], [[6ykg]], [[7jx0]], [[7kke]], [[7jwz]], [[7rsj]], [[7rsp]], [[7rsv]], [[7z61]] – hTI-PI3K p110γ + inhibitor <br /> |
| - | **[[3tjp]], [[4ezj]], [[4ezk]], [[4ezl]], [[4kz0]], [[4kzc]] - hTI-PI3K p110γ (mutant) + inhibitor<br /> | + | **[[3tjp]], [[4ezj]], [[4ezk]], [[4ezl]], [[4kz0]], [[4kzc]], [[6xrn]], [[6ykg]], [[7jx0]], [[7kke]], [[7jwz]], [[7rsj]], [[7rsp]], [[7rsv]] - hTI-PI3K p110γ (mutant) + inhibitor<br /> |
| + | **[[7jwe]] – hTI-PI3K p110γ + drug<br /> | ||
**[[3dpd]], [[6aud]] – hTI-PI3K p110γ + oxazines inhibitor <br /> | **[[3dpd]], [[6aud]] – hTI-PI3K p110γ + oxazines inhibitor <br /> | ||
**[[3dbs]] – hTI-PI3K p110γ + GDC0941 <br /> | **[[3dbs]] – hTI-PI3K p110γ + GDC0941 <br /> | ||
| Line 80: | Line 95: | ||
**[[3oaw]], [[3ml9]], [[3ml8]], [[3l17]], [[3l16]], [[3l13]], [[3pre]], [[3prz]], [[3ps6]], [[3qjz]], [[3qk0]] – hTI-PI3K p110γ + PI3K/mTOR dual inhibitor<br /> | **[[3oaw]], [[3ml9]], [[3ml8]], [[3l17]], [[3l16]], [[3l13]], [[3pre]], [[3prz]], [[3ps6]], [[3qjz]], [[3qk0]] – hTI-PI3K p110γ + PI3K/mTOR dual inhibitor<br /> | ||
**[[1he8]] - hTI-PI3K p110γ + transforming protein P21/H-RAS-1 effector domain<br /> | **[[1he8]] - hTI-PI3K p110γ + transforming protein P21/H-RAS-1 effector domain<br /> | ||
| + | **[[7mez]] - hTI-PI3K p110 + p101 – cryo EM<br /> | ||
| + | **[[8dp0]] - hTI-PI3K p110 catalytic subunit + nanobody – cryo EM<br /> | ||
| + | **[[8aj8]] - pTI-PI3K p110g catalytic subunit + regulatory subunit - pig<br /> | ||
*Type I PI3K p110δ | *Type I PI3K p110δ | ||
**[[2x38]] – hTI-PI3K p110δ + IC87114 <br /> | **[[2x38]] – hTI-PI3K p110δ + IC87114 <br /> | ||
| - | **[[2wxf]], [[2wxg]], [[2wxh]], [[2wxi]], [[2wxj]], [[2wxk]], [[2wxl]], [[2wxm]], [[2wxn]], [[2wxo]], [[2wxp]], [[2wxq]], [[2wxr]], [[4ajw]] – hTI-PI3K p110δ + inhibitor<br /> | + | **[[2wxf]], [[2wxg]], [[2wxh]], [[2wxi]], [[2wxj]], [[2wxk]], [[2wxl]], [[2wxm]], [[2wxn]], [[2wxo]], [[2wxp]], [[2wxq]], [[2wxr]], [[4ajw]], [[6g6w]], [[6pyr]], [[6pyu]], [[6oco]], [[6ocu]], [[7jis]], [[7jiu]], [[7lm2]] – hTI-PI3K p110δ + inhibitor<br /> |
| + | **[[6dgt]], [[6eyz]], [[6ez6]], [[6ftn]], [[6gy0]], [[6hi1]], [[6hi2]], [[6hi9]], [[6mul]], [[6mum]], [[6tnr]], [[6tns]], [[6zaa]], [[6zac]], [[6zad]], [[7oi4]], [[7oij]] [[7oil]], [[7ois]] [[7pop]], [[7por]], [[7pos]], [[7pot]] – mTI-PI3K p110δ + inhibitor<br /> | ||
| + | |||
| + | *Type I PI3K p150 | ||
| + | |||
| + | **[[8srq]] – hTI-PI3K p150 + p100 + ULK1C + C1 – Cryo EM<br /> | ||
| + | |||
| + | *Type I PI3K p100 | ||
| + | |||
| + | **[[8sor]] – hTI-PI3K p100 + C1 – Cryo EM<br /> | ||
}} | }} | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Current revision
3D Structures of PI3K
Updated on 27-August-2023
